EUVIMEDEUVIMED entdecken
Crossref

Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease

Aki Pirttilä, Miia Tiihonen, Anne Paakinaho, Sirpa Hartikainen, Anna-Maija Tolppanen

Journal of the American Medical Directors Association · 2023

DOI: 10.1016/j.jamda.2023.04.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Directors Association, 2023. Verfasst von Aki Pirttilä und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kuopio Research Center of Geriatric Care and School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Antipsychotic Agents, Clozapine, Parkinson Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The use of antipsychotics in persons with Parkinson's disease (PD) is common, although their use may aggravate the symptoms of PD. Clozapine and quetiapine are the only antipsychotics recommended in PD treatment guidelines. Information on factors associated with initiation of antipsychotics is needed. We investigated whether recent hospitalization is associated with initiation of antipsychotics in persons with PD, and whether discharge diagnoses differ between those who had antipsychotics initiated and those who did not. DESIGN: Nested case-control study in the nationwide register-based Finnish Study on Parkinson's disease (FINPARK). SETTING AND PARTICIPANTS: The FINPARK study includes 22,189 persons who received an incident, clinically verified PD diagnosed during 1996-2015 and were community-dwelling at the time of diagnosis. The cases were 5088 persons who had antipsychotics initiated after PD diagnosis, identified with 1-year washout. The controls were 5088 age-, sex-, and time from PD diagnosis-matched persons who did not use antipsychotics on the matching date (antipsychotic purchase date). Recent hospitalization was defined as discharge in the 2-week period preceding the matching date. METHODS: Associations were investigated with conditional logistic regression. RESULTS: Quetiapine was the most commonly initiated antipsychotic (72.0% of cases), followed by risperidone (15.0%). Clozapine was initiated rarely (1.1%). Recent hospitalization associated strongly with antipsychotic initiation [61.2% of cases and 14.9% of controls, odds ratio (OR) 9.42, 95% CI 8.33-10.65], and longer hospitalizations were more common among cases. PD was the most common discharge diagnosis category (51.2% of hospitalized cases and 33.0% controls), followed by mental and behavioral disorders (9.3%) and dementia (9.0%) among cases. Antidementia and other psychotropic medication use were more common among cases. CONCLUSIONS AND IMPLICATIONS: These results suggest that antipsychotics were initiated because of neuropsychiatric symptoms or aggravation of those symptoms. Antipsychotics should be prescribed after careful consideration to avoid adverse effects in persons with Parkinson's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsClozapineParkinson DiseaseHumansQuetiapine FumarateCase-Control StudiesHospitalization

Stichwörter der Autor:innen

Parkinson's diseaseantipsychoticscase-control studyhospitalizationspharmacoepidemiology

Substanzen

Antipsychotic AgentsQuetiapine FumarateClozapine

Autor:innen und Institutionen

  • Kuopio Research Center of Geriatric Care and School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Kuopio Research Center of Geriatric Care and School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Electronic address: anna-maija.tolppanen@uef.fi.

Zitieren

APA

Pirttilä, A., Tiihonen, M., Paakinaho, A., Hartikainen, S., & Tolppanen, A. M. (2023). Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2023.04.004

Vancouver

Pirttilä A, Tiihonen M, Paakinaho A, Hartikainen S, Tolppanen AM. Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease. Journal of the American Medical Directors Association. 2023. doi:10.1016/j.jamda.2023.04.004

BibTeX
@article{Pirttil2023,
  author = {Pirttilä, Aki and Tiihonen, Miia and Paakinaho, Anne and Hartikainen, Sirpa and Tolppanen, Anna-Maija},
  title = {Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease},
  journal = {Journal of the American Medical Directors Association},
  year = {2023},
  doi = {10.1016/j.jamda.2023.04.004}
}
Kostenlos starten →